Tidal Neonatal NO, Vitamins A and D, and Infant Lung Disease - The AD-ON Study
AD-ON: The Danish Study on Tidal Neonatal Nitrogen Oxide (NO) and Vitamins A and D as Possible Predictors of BPD
1 other identifier
observational
1,500
1 country
2
Brief Summary
Children born prematurely are of greater risk of developing chronic lung disease (Bronchopulmonary Dysplasia). With an increase in the amount of premature children, we expect an increasing number of children with BPD. Today we do not have many ways of predicting or treating this condition, and the children are usually in hospital for several months after birth. Many are dismissed with home oxygen. Children with BPD are typically often re-submitted to hospital with respiratory disease the first couple of years, and some of them have problems throughout childhood and into adulthood. Other scientists have found a correlation between BPD and Chronic Obstructive Pulmonary Disease (COPD). The condition as well as the treatment (steroids), are associated with great risk of adverse effects as Cerebral Palsy, blindness, deafness and mental retardation. The investigators wish to find a safe way to identify the children in greater risk of developing BPD, who could therefore benefit from a more intensive treatment.An early diagnosis would increase the possibility of predicting the prognosis. Other studies have proven a connection between both low vitamin A and D and high exhaled nitrogen oxide (NO) with lung disease. With this trial the investigators wish to make a reference material for NO and vitamins A and D in infants admitted to the neonatal department at two hospitals in Denmark, both with and without treatment with nasal Continuous Positive Airway Pressure. The investigators furthermore wish to describe an eventual connection between BPD and these factors by examining a large group of children on 7 specific occasions within the first two months of life and at a one year follow up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2013
Typical duration for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 24, 2012
CompletedFirst Posted
Study publicly available on registry
November 7, 2012
CompletedStudy Start
First participant enrolled
August 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2015
CompletedNovember 6, 2015
November 1, 2015
2.3 years
October 24, 2012
November 5, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Tidal exhaled Nitrogen Oxide
Reference material of tidal expiratory NO in a cohort of neonates admitted to Neonatal Intensive Care Unit and Neonatal Care Unit will be made. All children in the study will be measured on 8 occasions including a one year follow up. Association with Bronchopulmonary Dysplasia (BPD) and the measures above will be noted.
6-7 measures within the first 2 months of life and at 1 year of age.
Secondary Outcomes (1)
Vitamin levels
From birth to a one year follow up
Other Outcomes (1)
Bronchopulmonary Dysplasia
From premature birth to a one year follow up
Study Arms (1)
Term and preterm infants
Term and preterm infants
Interventions
Eligibility Criteria
Term and preterm infants admitted to Neonatal Care Unit for reference material as control group. Preterm infants admitted to Neonatal Intensive Care Unit developing BPD as study group.
You may not qualify if:
- Children with ciliary dyskinesia, as NO is distinguishable lower in these children.
- Children who can not cooperate to the examination.
- Children so dependant on oxygen, that the examination/measurement is not possible.
- Children with pneumothorax
- Children having a diagnosed pneumonia verified by tracheal secrete.
- Children with bigger congenital anomalies
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hillerod Hospital, Denmarklead
- Rigshospitalet, Denmarkcollaborator
Study Sites (2)
Neonatal departement GN, Rigshospitalet
Copenhagen, Region H, 2200, Denmark
Children´s Departement, North Zealand Hospital, Hilleroed
Hilleroed, Region H, 3400, Denmark
Biospecimen
Air samples for Nitrogen oxide NO. Maternal, cord and neonatal blood samples for vitamins A and D.
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Birgitte J Schmidt, MD
Children´s Dep, North Zealand Hospital Hilleroed, Denmark
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
October 24, 2012
First Posted
November 7, 2012
Study Start
August 1, 2013
Primary Completion
November 1, 2015
Study Completion
November 1, 2015
Last Updated
November 6, 2015
Record last verified: 2015-11